BoMRA Press Release Stakeholder Engagement November

BoMRA will conduct stakeholder sessions to discuss the regulatory requirements for medical devices.
BoMRA Press Release DPER Stakeholder engagements (October)

The Department of Product Evaluation & Registration at BoMRA will conduct stakeholder sessions to discuss the registration requirements for medical devices, veterinary medicines, human medicines
Expression of interest (Calibration of Infrared Thermometers)

The Botswana Medicines Regulatory Authority (BoMRA) is responsible for regulating the supply chain of human and veterinary medicines, medical devices and cosmetics to ensure their
Suspension Of Registration of GrandPa Products

The public, healthcare practitioners, importers and distributors are informed that registrations of Grand-Pa Headache products (Powder and tablets) have been suspended from the Botswana market
Call for Registration of medical devices distributors

Botswana Medicines Regulatory Authority (BoMRA) is calling on all entities trading in medical devices to register with the Authority.
Important Public Warning

Botswana Medicines Regulatory Authority (BoMRA) reminds consumers to be cautious of stores and websites selling products that claim to prevent, mitigate, treat, diagnose or cure
Ask your pharmacist about Covid-19

Pharmacists, like other frontline healthcare professionals, are risking their lives for the well-being of their patients during COVID-19 pandemic. Here is what you can do
Public Warning-Unfounded Claims

Botswana Medicines Regulatory Authority (BoMRA) reminds consumers to be cautious of stores and websites selling products that claim to prevent, mitigate, treat, diagnose or cure
Press release (Ranitidine)

The Botswana Medicines Regulatory Authority wishes to inform the public of a potential safety issue in Ranitidine containing products. The presence of nitrosamine impurity called
Press Release – Ranitidine Recall

The General Public is informed that the Botswana Medicines Regulatory Authority (BOMRA) has recalled with immediate effect from the market, ALL RANITIDINE containing medicines registered






